Abstract: Provided are novel heterocyclic sirtuin binding agents, e.g., N-aryl substituted pyridine dicarboxamides, which are useful as sirtuin modulators. Also provided are methods of using the pyridine dicarboxamide compounds for treating sirtuin mediated disorders and conditions, such as diabetes, cancers, and obesity and diseases related to aging.
Type:
Application
Filed:
December 12, 2012
Publication date:
November 6, 2014
Applicant:
SMB Innovation
Inventors:
Bjarne Due Larsen, Soren Andersen, Marianne Spanget Larsen